The European Union’s drug regulator on Monday gave the approval to administer booster shots of the Pfizer-BioNTech COVID-19 vaccine dubbed Comirnaty to people aged 18 and older. “The [Committee for Medicinal Products for Human Use] has evaluated data for Comirnaty showing a rise in antibody levels when a booster dose is given approximately 6 months…
Pfizer Submits Data for COVID-19 Vaccine in Children 5 to 11
Pfizer and its German partner on Tuesday said they submitted data concerning results of a COVID-19 vaccine trial in children as young as 5. Pfizer and BioNTech sent the data to the U.S. Food and Drug Administration (FDA). The data is from a Phase 2/3 trial examining the companies’ COVID-19 shot in children 5 to…
Pfizer Starts New Study of Oral Drug for Prevention of COVID-19
Pfizer has started a global study to explore the efficacy and safety of an oral drug meant to prevent COVID-19, the disease caused by the CCP (Chinese Communist Party) virus. Pfizer’s Phase 2/3 study will evaluate the drug candidate, PF-07321332, in participants who live in the same household as a person who has a confirmed COVID-19 infection. Participants…
Pfizer CEO Predicts Annual COVID-19 Vaccinations
People will end up needing an annual COVID-19 shot, Pfizer’s CEO predicts. Moderna’s CEO Stéphane Bancel said last week he believes the COVID-19 pandemic will end next year. He said more and more people will get a COVID-19 vaccine and those who don’t will gain natural immunity, or protection against infection from contracting the disease and…
Pfizer’s Israel ‘Experiment’ Reveals Likely Future
A Pfizer executive has described Israel as a unique “laboratory” to assess COVID jab effects, saying whatever happens there can reliably be expected to happen elsewhere, months later. Israel’s N12 News obtained a recording of a Zoom meeting with academics in which a Pfizer vice president and its chief scientist, Dr. Philip Dormitizer, discussed the…
Expert Urges Australian States to Reduce Pfizer Dose Intervals
A leading Australian epidemiologist has urged the New South Wales (NSW) and Victorian state governments to return the Pfizer dose interval from 6 weeks to 28 days so that more young adults under 40 can receive their second vaccination. Speaking to ABC News Breakfast on Sept. 27, Marylouise McLaws, epidemiologist and professor at University of…
DHS Founding Member: DNA Affected by mRNA Could be Patented by Vaccine Manufacturers, Raising Social Concerns
With the new vaccine mandates, one of the common concerns is the safety of mRNA vaccines. A key issue is how patents work for DNA modified by mRNA, which could allow for DNA produced through its interactions to be patented by mRNA vaccine manufacturers like Pfizer or Moderna. To learn more about this, and what…
CDC Advisory Panel Could Vote on Pfizer COVID-19 Vaccine Booster
The Centers for Disease Control and Prevention (CDC) advisory panel could vote on the use of a third shot of Pfizer’s COVID-19 vaccine on Thursday. The panel is holding a virtual, two-day meeting. At the start of the discussion, which includes presentations from Pfizer, a CDC official said the advisory panel vote could take place…
More Than 30 Companies, Including Amazon, Facebook and Pfizer Vow to Create Economic Opportunities for Afghan Refugees
More than 30 companies including Amazon, Facebook, Pfizer, and Tyson Foods have vowed to create economic opportunities and provide resources for Afghan refugees as they start their new lives in the United States. The 34 companies, which stem from all sectors including tech, retail, and food service industry, have joined the Tent Coalition for Afghan Refugees, which…
US to Donate 500 Million More COVID-19 Vaccines to Poor Countries
The United States has reached an agreement with Pfizer to buy an additional 500 million doses of its COVID-19 vaccine to donate to various countries, according to the Biden administration. President Joe Biden plans to announce the agreement Wednesday, a senior administration official told reporters on a call on Sept. 21. “President Biden will announce…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`